# Autologous Dendritic Cell as Adjunct Therapy for Diabetic Kidney Disease

> **NCT06866158** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **PT. JES Kasih Nusantara Sejahterah** · enrollment: 80 (actual)

## Conditions studied

- Diabetic Kidney Disease (DKD)

## Interventions

- **BIOLOGICAL:** Dendritic cell immunotherapy

## Key facts

- **NCT ID:** NCT06866158
- **Lead sponsor:** PT. JES Kasih Nusantara Sejahterah
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-05-01
- **Primary completion:** 2024-08-05
- **Final completion:** 2026-08-05
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2025-12-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06866158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06866158, "Autologous Dendritic Cell as Adjunct Therapy for Diabetic Kidney Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06866158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*